Company: RGBP
Filing Date: 2025-08-01
Form Type: 8-K
Source: 0001641172-25-021882
Chunk: 1

Company: Regen BioPharma Inc
Filing Date: 2025-08-01
Form: 8-K
Item: Item 3.02
Chunk 1
---
Item
3.02 Recent Sales of Unregistered Securities

On
July 28, 2925 Regen Biopharma, Inc. (the “ Company”) entered into a securities purchase agreement (the “ Purchase Agreement”)
withCFI Capital LLC(“ CFI”), pursuant to which CFI purchased a 6% convertible promissory Note (the “ Note”)
from the Company in the principal amount of $130,000 of which $13,000 was retained by CFI through an Original Issue Discount. The Note
is due and payable on July 28, 2026.

The
Holder of this Note is entitled, at its option, at any time after the 6th monthly anniversary of this Note, to convert all or any amount
of the principal face amount of this Note then outstanding into shares of the Company’s common stock (the “ Common Stock”)
at a price (“ Conversion Price”) for each share of Common Stock equal to 60% of the lowest trading price of the Common Stock
as reported on the OTC Markets on which the Company’s shares are then traded or any exchange up-on which the Common Stock may be
traded in the future (the “ Exchange”), for the twenty prior trading days including the day upon which a Notice of Conversion
is received by the Company.

The
foregoing description of the abovementioned Note is not complete and is qualified in its entirety by reference to the text of the abovementioned
Note which is attached to this Current Report on Form 8-K as Exhibit 10.1 and incorporated in this Item 3.02 by reference.

Item
9.01 Financial Statements and Exhibits